173 related articles for article (PubMed ID: 19550422)
1. Identification of macrophage migration inhibitory factor and human neutrophil peptides 1-3 as potential biomarkers for gastric cancer.
Mohri Y; Mohri T; Wei W; Qi YJ; Martin A; Miki C; Kusunoki M; Ward DG; Johnson PJ
Br J Cancer; 2009 Jul; 101(2):295-302. PubMed ID: 19550422
[TBL] [Abstract][Full Text] [Related]
2. Increased epithelial and serum expression of macrophage migration inhibitory factor (MIF) in gastric cancer: potential role of MIF in gastric carcinogenesis.
He XX; Yang J; Ding YW; Liu W; Shen QY; Xia HH
Gut; 2006 Jun; 55(6):797-802. PubMed ID: 16488898
[TBL] [Abstract][Full Text] [Related]
3. Human neutrophil peptides 1-3 as gastric cancer tissue markers measured by MALDI-imaging mass spectrometry: implications for infiltrated neutrophils as a tumor target.
Cheng CC; Chang J; Chen LY; Ho AS; Huang KJ; Lee SC; Mai FD; Chang CC
Dis Markers; 2012; 32(1):21-31. PubMed ID: 22297599
[TBL] [Abstract][Full Text] [Related]
4. Five serum proteins identified using SELDI-TOF-MS as potential biomarkers of gastric cancer.
Lu HB; Zhou JH; Ma YY; Lu HL; Tang YL; Zhang QY; Zhao CH
Jpn J Clin Oncol; 2010 Apr; 40(4):336-42. PubMed ID: 20089528
[TBL] [Abstract][Full Text] [Related]
5. Macrophage migration inhibitory factor as a potential prognostic factor in gastric cancer.
He LJ; Xie D; Hu PJ; Liao YJ; Deng HX; Kung HF; Zhu SL
World J Gastroenterol; 2015 Sep; 21(34):9916-26. PubMed ID: 26379396
[TBL] [Abstract][Full Text] [Related]
6. Analysis of variabilities of serum proteomic spectra in patients with gastric cancer before and after operation.
Ren H; Du N; Liu G; Hu HT; Tian W; Deng ZP; Shi JS
World J Gastroenterol; 2006 May; 12(17):2789-92. PubMed ID: 16718772
[TBL] [Abstract][Full Text] [Related]
7. Serum macrophage migration-inhibitory factor as a diagnostic and prognostic biomarker for gastric cancer.
Xia HH; Yang Y; Chu KM; Gu Q; Zhang YY; He H; Wong WM; Leung SY; Yuen ST; Yuen MF; Chan AO; Wong BC
Cancer; 2009 Dec; 115(23):5441-9. PubMed ID: 19685530
[TBL] [Abstract][Full Text] [Related]
8. Identification of peptide regions of SERPINA1 and ENOSF1 and their protein expression as potential serum biomarkers for gastric cancer.
Yang J; Xiong X; Wang X; Guo B; He K; Huang C
Tumour Biol; 2015 Jul; 36(7):5109-18. PubMed ID: 25677901
[TBL] [Abstract][Full Text] [Related]
9. Identification of a high molecular weight kininogen fragment as a marker for early gastric cancer by serum proteome analysis.
Umemura H; Togawa A; Sogawa K; Satoh M; Mogushi K; Nishimura M; Matsushita K; Tanaka H; Takizawa H; Kodera Y; Nomura F
J Gastroenterol; 2011 May; 46(5):577-85. PubMed ID: 21298293
[TBL] [Abstract][Full Text] [Related]
10. Mining novel biomarkers for prognosis of gastric cancer with serum proteomics.
Qiu FM; Yu JK; Chen YD; Jin QF; Sui MH; Huang J
J Exp Clin Cancer Res; 2009 Sep; 28(1):126. PubMed ID: 19740432
[TBL] [Abstract][Full Text] [Related]
11. [Search for potential gastric cancer biomarkers using low molecular weight blood plasma proteome profiling by mass spectrometry].
Shevchenko VE; Arnotskaia NE; Ogorodnikova EV; Davydov MM; Ibraev MA; Turkin IN; Davydov MI
Biomed Khim; 2014; 60(4):503-14. PubMed ID: 25249535
[TBL] [Abstract][Full Text] [Related]
12. The diagnostic value of macrophage migration inhibitory factor (MIF) in gastric cancer.
Camlica H; Duranyildiz D; Oguz H; Oral EN; Yasasever V
Pathol Oncol Res; 2008 Mar; 14(1):79-83. PubMed ID: 18347935
[TBL] [Abstract][Full Text] [Related]
13. [Use of serum protein profiling for early diagnosis of gastric cancer].
Zheng ZG; Xu SH; Xu Q; Zhu CH; Yu CD
Zhonghua Wei Chang Wai Ke Za Zhi; 2010 Oct; 13(10):770-3. PubMed ID: 20972910
[TBL] [Abstract][Full Text] [Related]
14. Identification of carboxyl terminal peptide of Fibrinogen as a potential serum biomarker for gastric cancer.
Wu C; Luo Z; Tang D; Liu L; Yao D; Zhu L; Wang Z
Tumour Biol; 2016 May; 37(5):6963-70. PubMed ID: 26662807
[TBL] [Abstract][Full Text] [Related]
15. MALDI/SELDI protein profiling of serum for the identification of cancer biomarkers.
Cazares LH; Diaz JI; Drake RR; Semmes OJ
Methods Mol Biol; 2008; 428():125-40. PubMed ID: 18287771
[TBL] [Abstract][Full Text] [Related]
16. Proteomic biomarker predicts therapeutical effects of oxaliplatin combining with fluoropyrimidine in metastatic gastric cancer patients by the SELDI-proteinchip platform.
Yu Z; Yu JK; Fang XF; Yuan Y; Shen H
Hepatogastroenterology; 2013 Oct; 60(127):1800-4. PubMed ID: 24624447
[TBL] [Abstract][Full Text] [Related]
17. A serum proteomic pattern for the detection of colorectal adenocarcinoma using surface enhanced laser desorption and ionization mass spectrometry.
Liu XP; Shen J; Li ZF; Yan L; Gu J
Cancer Invest; 2006 Dec; 24(8):747-53. PubMed ID: 17162557
[TBL] [Abstract][Full Text] [Related]
18. Detection of Serum Protein Biomarkers for the Diagnosis and Staging of Hepatoblastoma.
Zhao W; Li J; Zhang J; Gao P; Pei H; Wang L; Guo F; Yu J; Zheng S; Wang J
Int J Mol Sci; 2015 Jun; 16(6):12669-85. PubMed ID: 26053398
[TBL] [Abstract][Full Text] [Related]
19. [Screen and identification of serum protein biomarkers in gastric cancer].
Zhang H; Li H; Guo F; Zhang D; Yang H; Wang J
Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Mar; 19(3):317-22. PubMed ID: 27003656
[TBL] [Abstract][Full Text] [Related]
20. Diagnosis of gastric cancer by serum proteomic fingerprinting.
Poon TC; Sung JJ; Chow SM; Ng EK; Yu AC; Chu ES; Hui AM; Leung WK
Gastroenterology; 2006 May; 130(6):1858-64. PubMed ID: 16697748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]